Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.45 USD | -0.05% | +1.07% | +25.64% |
Mar. 08 | Novo Nordisk hopes to launch experimental obesity drug this decade | RE |
Mar. 07 | Transcript : Catalent, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.64% | 10.2B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Catalent, Inc. - Nyse
- News Catalent, Inc.
- Catalent to Acquire Metrics Contract Services for $475 Million